Zhongchao (NASDAQ:ZCMD) Stock Rating Raised to Hold at Wall Street Zen
by Jessica Moore · The Cerbat GemWall Street Zen upgraded shares of Zhongchao (NASDAQ:ZCMD – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings downgraded shares of Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, September 25th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.
Read Our Latest Report on Zhongchao
Zhongchao Stock Performance
Shares of ZCMD stock opened at $1.85 on Friday. Zhongchao has a one year low of $1.42 and a one year high of $1,934.40. The company’s fifty day moving average price is $1.91 and its 200-day moving average price is $123.19.
About Zhongchao
Zhongchao Inc is a China-based healthcare services company that provides medical education and patient-management services. The company focuses on supporting healthcare professionals and patients through digital platforms, educational programs and related healthcare resources.
Its business activities have included continuing medical education for physicians and other medical professionals, as well as disease-management and patient-support services. Zhongchao has particularly emphasized oncology-related healthcare education and management, helping connect medical information, professional training and patient services.
The company primarily serves the healthcare market in China through online and offline offerings.